MACROGENICS, INC. Operating Income
MACROGENICS, INC. (MGNX) reported Operating Income of -$13.85 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-14
- MACROGENICS, INC. operating income (loss) for the quarter ending 2026-06-30 was -$13.85M.
- MACROGENICS, INC. operating income (loss) for the quarter ending 2026-03-31 was -$33.44M.
- MACROGENICS, INC. operating income (loss) for the quarter ending 2025-12-31 was -$12.10M.
- MACROGENICS, INC. operating income (loss) for the quarter ending 2025-09-30 was $18.64M, a 65.61% decline year-over-year.
- MACROGENICS, INC. operating income (loss) for fiscal 2025 was -$72.84M.
- MACROGENICS, INC. operating income (loss) for fiscal 2024 was -$110.58M.
- MACROGENICS, INC. operating income (loss) for fiscal 2023 was -$168.24M.
- MACROGENICS, INC. operating income (loss) for fiscal 2022 was -$121.42M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$13.85M 10-Q · filed 2026-08-14 | -$51.81M 10-Q · filed 2026-08-14 | -$59.39M derived: sum of 3 quarters · filed 2026-08-14 | -$40.75M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | -$33.44M 10-Q · filed 2026-05-13 | -$45.54M derived: sum of 2 quarters · filed 2026-05-13 | -$26.90M derived: sum of 3 quarters · filed 2026-05-13 | -$70.12M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | -$12.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $6.54M derived: sum of 2 quarters · filed 2026-03-09 | -$36.69M derived: sum of 3 quarters · filed 2026-08-14 | -$72.84M 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | $18.64M 10-Q · filed 2025-11-12 | -$24.59M derived: sum of 2 quarters · filed 2026-08-14 | -$60.74M 10-Q · filed 2025-11-12 | -$120.05M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | -$43.22M 10-Q · filed 2026-08-14 | -$36.76M 10-Q · filed 2025-08-14 | -$86.60M 10-Q · filed 2026-08-14 | -$79.38M 10-Q · filed 2025-08-14 | -$138.69M derived: sum of 3 quarters · filed 2026-08-14 | -$84.49M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | -$42.62M 10-Q · filed 2026-05-13 | -$95.46M derived: sum of 2 quarters · filed 2026-05-13 | -$41.27M derived: sum of 3 quarters · filed 2026-05-13 | -$99.45M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$52.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $1.35M derived: sum of 2 quarters · filed 2026-03-09 | -$56.83M derived: sum of 3 quarters · filed 2026-03-09 | -$110.58M 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | $54.19M 10-Q · filed 2025-11-12 | -$3.99M derived: sum of 2 quarters · filed 2025-11-12 | -$57.74M 10-Q · filed 2025-11-12 | -$107.09M derived: sum of 4 quarters · filed 2026-03-09 | ||||
| 2024-06-30 | -$58.18M 10-Q · filed 2025-08-14 | -$111.93M 10-Q · filed 2025-08-14 | -$161.28M derived: sum of 3 quarters · filed 2026-03-09 | -$196.79M derived: sum of 4 quarters · filed 2026-03-09 | ||||
| 2024-03-31 | -$53.75M 10-Q · filed 2025-05-13 | -$103.10M derived: sum of 2 quarters · filed 2026-03-09 | -$138.61M derived: sum of 3 quarters · filed 2026-03-09 | -$183.57M derived: sum of 4 quarters · filed 2026-03-09 | ||||
| 2023-12-31 | -$49.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$84.86M derived: sum of 2 quarters · filed 2026-03-09 | -$129.82M derived: sum of 3 quarters · filed 2026-03-09 | -$168.24M 10-K · filed 2026-03-09 | ||||
| 2023-09-30 | -$35.50M 10-Q · filed 2024-11-05 | -$80.46M derived: sum of 2 quarters · filed 2024-11-05 | -$118.89M 10-Q · filed 2024-11-05 | -$106.91M derived: sum of 4 quarters · filed 2025-03-20 | ||||
| 2023-06-30 | -$44.96M 10-Q · filed 2024-08-06 | -$83.39M 10-Q · filed 2024-08-06 | -$71.41M derived: sum of 3 quarters · filed 2025-03-20 | -$96.36M derived: sum of 4 quarters · filed 2025-03-20 | ||||
| 2023-03-31 | -$38.43M 10-Q · filed 2024-05-09 | -$26.44M derived: sum of 2 quarters · filed 2025-03-20 | -$51.40M derived: sum of 3 quarters · filed 2025-03-20 | -$93.21M derived: sum of 4 quarters · filed 2025-03-20 | ||||
| 2022-12-31 | $11.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$12.97M derived: sum of 2 quarters · filed 2025-03-20 | -$54.78M derived: sum of 3 quarters · filed 2025-03-20 | -$121.42M 10-K · filed 2025-03-20 | ||||
| 2022-09-30 | -$24.95M 10-Q · filed 2023-11-06 | -$66.76M derived: sum of 2 quarters · filed 2023-11-06 | -$133.40M 10-Q · filed 2023-11-06 | -$191.64M derived: sum of 4 quarters · filed 2024-03-07 | ||||
| 2022-06-30 | -$41.81M 10-Q · filed 2023-08-09 | -$108.45M 10-Q · filed 2023-08-09 | -$166.68M derived: sum of 3 quarters · filed 2024-03-07 | -$219.67M derived: sum of 4 quarters · filed 2024-03-07 | ||||
| 2022-03-31 | -$66.64M 10-Q · filed 2023-05-09 | -$124.87M derived: sum of 2 quarters · filed 2024-03-07 | -$177.86M derived: sum of 3 quarters · filed 2024-03-07 | -$218.14M derived: sum of 4 quarters · filed 2024-03-07 | ||||
| 2021-12-31 | -$58.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$111.22M derived: sum of 2 quarters · filed 2024-03-07 | -$151.50M derived: sum of 3 quarters · filed 2024-03-07 | -$202.79M 10-K · filed 2024-03-07 | ||||
| 2021-09-30 | -$52.99M 10-Q · filed 2022-11-03 | -$93.27M derived: sum of 2 quarters · filed 2022-11-03 | -$144.56M 10-Q · filed 2022-11-03 | -$146.73M derived: sum of 4 quarters · filed 2023-03-15 | ||||
| 2021-06-30 | -$40.28M 10-Q · filed 2022-08-08 | -$91.57M 10-Q · filed 2022-08-08 | -$93.74M derived: sum of 3 quarters · filed 2023-03-15 | -$129.88M derived: sum of 4 quarters · filed 2023-03-15 | ||||
| 2021-03-31 | -$51.29M 10-Q · filed 2022-05-03 | -$53.46M derived: sum of 2 quarters · filed 2023-03-15 | -$89.60M derived: sum of 3 quarters · filed 2023-03-15 | -$136.91M derived: sum of 4 quarters · filed 2023-03-15 | ||||
| 2020-12-31 | -$2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$38.30M derived: sum of 2 quarters · filed 2023-03-15 | -$85.61M derived: sum of 3 quarters · filed 2023-03-15 | -$131.06M 10-K · filed 2023-03-15 | ||||
| 2020-09-30 | -$36.13M 10-Q · filed 2021-11-02 | -$83.44M derived: sum of 2 quarters · filed 2021-11-02 | -$128.89M 10-Q · filed 2021-11-02 | -$167.54M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | -$47.31M 10-Q · filed 2021-07-29 | -$92.75M 10-Q · filed 2021-07-29 | -$131.41M derived: sum of 3 quarters · filed 2022-02-24 | -$169.35M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | -$45.45M 10-Q · filed 2021-04-29 | -$84.10M derived: sum of 2 quarters · filed 2022-02-24 | -$122.04M derived: sum of 3 quarters · filed 2022-02-24 | -$175.01M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | -$38.66M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$76.60M derived: sum of 2 quarters · filed 2022-02-24 | -$129.57M derived: sum of 3 quarters · filed 2022-02-24 | -$177.19M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | -$37.94M 10-Q · filed 2020-11-04 | -$90.91M derived: sum of 2 quarters · filed 2020-11-04 | -$138.53M 10-Q · filed 2020-11-04 | -$180.21M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | -$52.97M 10-Q · filed 2020-07-31 | -$100.59M 10-Q · filed 2020-07-31 | -$142.26M derived: sum of 3 quarters · filed 2021-02-25 | -$177.27M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | -$47.62M 10-Q · filed 2020-05-05 | -$89.30M derived: sum of 2 quarters · filed 2021-02-25 | -$124.30M derived: sum of 3 quarters · filed 2021-02-25 | -$168.61M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | -$41.68M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$76.68M derived: sum of 2 quarters · filed 2021-02-25 | -$121.00M derived: sum of 3 quarters · filed 2021-02-25 | -$171.21M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | -$35.00M 10-Q · filed 2019-11-06 | -$79.32M derived: sum of 2 quarters · filed 2019-11-06 | -$129.53M 10-Q · filed 2019-11-06 | -$24.56M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-06-30 | -$44.31M 10-Q · filed 2019-07-31 | -$94.52M 10-Q · filed 2019-07-31 | $10.45M derived: sum of 3 quarters · filed 2020-02-25 | -$37.28M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-03-31 | -$50.21M 10-Q · filed 2019-05-01 | $54.76M derived: sum of 2 quarters · filed 2020-02-25 | $7.04M derived: sum of 3 quarters · filed 2020-02-25 | -$34.14M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2017-12-31 | $104.97M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $57.24M derived: sum of 2 quarters · filed 2020-02-25 | $16.07M derived: sum of 3 quarters · filed 2020-02-25 | -$22.14M 10-K · filed 2020-02-25 | ||||
| 2017-09-30 | -$47.72M 10-Q · filed 2018-11-07 | -$88.90M derived: sum of 2 quarters · filed 2018-11-07 | -$127.11M 10-Q · filed 2018-11-07 | -$162.35M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | -$41.18M 10-Q · filed 2018-08-07 | -$79.39M 10-Q · filed 2018-08-07 | -$114.63M derived: sum of 3 quarters · filed 2019-02-26 | -$148.89M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | -$38.21M 10-Q · filed 2018-05-07 | -$73.45M derived: sum of 2 quarters · filed 2019-02-26 | -$107.71M derived: sum of 3 quarters · filed 2019-02-26 | -$67.62M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | -$35.24M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$69.50M derived: sum of 2 quarters · filed 2019-02-26 | -$29.41M derived: sum of 3 quarters · filed 2019-02-26 | -$60.04M 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | -$34.27M 10-Q · filed 2017-11-08 | $5.83M derived: sum of 2 quarters · filed 2017-11-08 | -$24.80M 10-Q · filed 2017-11-08 | -$53.38M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $40.09M 10-Q · filed 2017-08-02 | $9.46M 10-Q · filed 2017-08-02 | -$19.12M derived: sum of 3 quarters · filed 2018-02-27 | -$34.56M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | -$30.63M 10-Q · filed 2017-05-03 | -$59.21M derived: sum of 2 quarters · filed 2018-02-27 | -$74.66M derived: sum of 3 quarters · filed 2018-02-27 | -$95.95M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | -$28.58M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$44.02M derived: sum of 2 quarters · filed 2018-02-27 | -$65.31M derived: sum of 3 quarters · filed 2018-02-27 | -$20.18M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | -$15.44M 10-Q · filed 2016-11-02 | -$36.73M derived: sum of 2 quarters · filed 2016-11-02 | $8.40M 10-Q · filed 2016-11-02 | -$10.62M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | -$21.29M 10-Q · filed 2016-08-03 | $23.84M 10-Q · filed 2016-08-03 | $4.82M derived: sum of 3 quarters · filed 2017-02-28 | $895.00K derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $45.13M 10-Q · filed 2016-05-04 | $26.11M derived: sum of 2 quarters · filed 2017-02-28 | $22.18M derived: sum of 3 quarters · filed 2017-02-28 | $9.93M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | -$19.02M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$22.95M derived: sum of 2 quarters · filed 2017-02-28 | -$35.21M derived: sum of 3 quarters · filed 2017-02-28 | -$38.31M 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | -$3.93M 10-Q · filed 2015-11-04 | -$16.19M derived: sum of 2 quarters · filed 2015-11-04 | -$19.30M 10-Q · filed 2015-11-04 | -$22.50M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | -$12.26M 10-Q · filed 2015-08-05 | -$15.37M 10-Q · filed 2015-08-05 | -$18.57M derived: sum of 3 quarters · filed 2016-02-29 | -$11.41M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | -$3.11M 10-Q · filed 2015-05-06 | -$3.11M 10-Q · filed 2014-05-06 | -$6.31M derived: sum of 2 quarters · filed 2016-02-29 | $845.00K derived: sum of 3 quarters · filed 2016-02-29 | $591.00K derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | -$3.21M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $3.95M derived: sum of 2 quarters · filed 2016-02-29 | $3.70M derived: sum of 3 quarters · filed 2016-02-29 | $366.00K 10-K · filed 2016-02-29 | $365.98K 10-K · filed 2014-03-20 | |||
| 2013-09-30 | $7.16M 10-Q · filed 2014-11-12 | $7.16M 10-Q · filed 2013-11-12 | $6.90M derived: sum of 2 quarters · filed 2014-11-12 | $3.57M 10-Q · filed 2014-11-12 | $3.57M 10-Q · filed 2013-11-12 | $1.32M derived: sum of 4 quarters · filed 2015-03-03 | ||
| 2013-06-30 | -$254.00K 10-Q · filed 2014-08-05 | -$3.59M 10-Q · filed 2014-08-05 | -$5.84M derived: sum of 3 quarters · filed 2015-03-03 | -$3.24M derived: sum of 4 quarters · filed 2015-03-03 | ||||
| 2013-03-31 | -$3.33M 10-Q · filed 2014-05-06 | -$5.59M derived: sum of 2 quarters · filed 2015-03-03 | -$2.99M derived: sum of 3 quarters · filed 2015-03-03 | |||||
| 2012-12-31 | -$2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $342.13K derived: sum of 2 quarters · filed 2015-03-03 | $8.21M 10-K · filed 2015-03-03 | $8.21M 10-K · filed 2014-03-20 | ||||
| 2012-09-30 | $2.60M 10-Q · filed 2013-11-12 | $10.46M 10-Q · filed 2013-11-12 | ||||||
| 2011-12-31 | $5.25M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |